Merit Medical Systems Inc
NASDAQ:MMSI

Watchlist Manager
Merit Medical Systems Inc Logo
Merit Medical Systems Inc
NASDAQ:MMSI
Watchlist
Price: 105.33 USD 0.29% Market Closed
Market Cap: 6.1B USD
Have any thoughts about
Merit Medical Systems Inc?
Write Note

Merit Medical Systems Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Merit Medical Systems Inc
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Merit Medical Systems Inc
NASDAQ:MMSI
Accrued Liabilities
$138.7m
CAGR 3-Years
-3%
CAGR 5-Years
9%
CAGR 10-Years
16%
Haemonetics Corp
NYSE:HAE
Accrued Liabilities
$49.3m
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
-1%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Accrued Liabilities
$675m
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
7%
ICU Medical Inc
NASDAQ:ICUI
Accrued Liabilities
$297.8m
CAGR 3-Years
50%
CAGR 5-Years
20%
CAGR 10-Years
33%
Align Technology Inc
NASDAQ:ALGN
Accrued Liabilities
$574.6m
CAGR 3-Years
4%
CAGR 5-Years
15%
CAGR 10-Years
21%
Lantheus Holdings Inc
NASDAQ:LNTH
Accrued Liabilities
$161.7m
CAGR 3-Years
52%
CAGR 5-Years
37%
CAGR 10-Years
17%
No Stocks Found

Merit Medical Systems Inc
Glance View

Market Cap
6.1B USD
Industry
Health Care

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 6,446 full-time employees. The Company’s segments include cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. The endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products, including peripheral intervention, cardiac intervention, custom procedural solutions, original equipment manufacturer and endoscopy.

MMSI Intrinsic Value
87.16 USD
Overvaluation 17%
Intrinsic Value
Price

See Also

What is Merit Medical Systems Inc's Accrued Liabilities?
Accrued Liabilities
138.7m USD

Based on the financial report for Sep 30, 2024, Merit Medical Systems Inc's Accrued Liabilities amounts to 138.7m USD.

What is Merit Medical Systems Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
16%

Over the last year, the Accrued Liabilities growth was 6%. The average annual Accrued Liabilities growth rates for Merit Medical Systems Inc have been -3% over the past three years , 9% over the past five years , and 16% over the past ten years .

Back to Top